US$ 26.63
glp-1 obesity drug news today october 23 2025 Massachusetts cuts coverage for 460K public workers and retirees, jeopardizing care and risking higher long-term health costs. Learn more New Daily GLP-1 Weight Loss
Description
Currently, no pharmacotherapies are available for the treatment of NAFLD/NASH and the disease is managed by targeting lifestyle changes and treating cardiometabolic risk factors [61]

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism

B., Mentz, R
Eur J Pharmacol (2021) 908:174310

World J Metaanal 2015;3:254-83.Article 58
